๎
๎ผ
๋ก๊ทธ์ธ
๎
Novabridge Biosciences ADR
NBP2.245USD
-0.305-11.96%
์ข
๊ฐย 03/30, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
258.83M์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ ํ์ฌ
Novabridge Biosciences ADR ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ - -
ํ์ฌ ์ด๋ฆ- -
์์ฅ์ผ- -
CEO- -
์ง์ ์- -
์ ํ- -
ํ๊ณ ์ฐ๋ ์ข
๋ฃ- -
์ฃผ์- -
๋์- -
์ฆ๊ถ ๊ฑฐ๋์- -
๊ตญ๊ฐ- -
์ฐํธ ๋ฒํธ- -
์ ํ- -
์น์ฌ์ดํธ- -
์ข
๋ชฉ ์ฝ๋ - -
์์ฅ์ผ- -
CEO- -
Novabridge Biosciences ADR์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Wei Fu
Mr. Wei Fu
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Chun Kwok (Alan) Au
Mr. Chun Kwok (Alan) Au
Independent Director
Independent Director
--
--
Mr. Chia-Hung (Conor) Yang
Mr. Chia-Hung (Conor) Yang
Independent Director
Independent Director
--
--
Dr. Phillip Dennis, M.D., Ph.D.
Dr. Phillip Dennis, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Xi-Yong (Sean) Fu, Ph.D.
Dr. Xi-Yong (Sean) Fu, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Robert Lenz, M.D., Ph.D.
Dr. Robert Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
,
,
Independent Director
Independent Director
--
--
,
,
Chief Business Development Officer, Director
Chief Business Development Officer, Director
--
--
Mr. Kyler Lei
Mr. Kyler Lei
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Claire Xu
Mr. Claire Xu
Senior Vice President - Clinical Development
Senior Vice President - Clinical Development
--
--
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Wei Fu
Mr. Wei Fu
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Chun Kwok (Alan) Au
Mr. Chun Kwok (Alan) Au
Independent Director
Independent Director
--
--
Mr. Chia-Hung (Conor) Yang
Mr. Chia-Hung (Conor) Yang
Independent Director
Independent Director
--
--
Dr. Phillip Dennis, M.D., Ph.D.
Dr. Phillip Dennis, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Xi-Yong (Sean) Fu, Ph.D.
Dr. Xi-Yong (Sean) Fu, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Robert Lenz, M.D., Ph.D.
Dr. Robert Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
์์ต ๋ถ์
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ง์ญ๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
China (Mainland)
0.00
0.00%
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Everest Medicines Ltd
13.74%
CBC Group
11.48%
Janus Henderson Investors
7.32%
T Investment Ltd
7.09%
HHLR Advisors, Ltd.
5.19%
๊ธฐํ
55.18%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Everest Medicines Ltd
13.74%
CBC Group
11.48%
Janus Henderson Investors
7.32%
T Investment Ltd
7.09%
HHLR Advisors, Ltd.
5.19%
๊ธฐํ
55.18%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Corporation
20.83%
Investment Advisor/Hedge Fund
14.49%
Private Equity
11.48%
Hedge Fund
7.09%
Investment Advisor
5.79%
Research Firm
3.95%
Individual Investor
0.56%
Venture Capital
0.31%
๊ธฐํ
35.48%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Jan 21
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Jan 21
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q4
71
44.19M
22.87%
--
2025Q4
112
44.52M
38.63%
+8.34M
2025Q3
118
43.87M
38.07%
+959.09K
2025Q2
118
26.13M
31.79%
-13.78M
2025Q1
122
24.15M
29.39%
-18.93M
2024Q4
134
22.41M
27.40%
-20.19M
2024Q3
146
29.96M
36.94%
-20.28M
2024Q2
191
30.91M
38.11%
-23.68M
2024Q1
262
28.58M
35.04%
-19.41M
2023Q4
293
28.92M
35.46%
-21.29M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Everest Medicines Ltd
15.85M
13.74%
+15.85M
--
Aug 05, 2025
CBC Group
11.95M
10.37%
-2.64M
-18.11%
Aug 05, 2025
Janus Henderson Investors
7.99M
6.93%
+7.99M
--
Sep 30, 2025
T Investment Ltd
8.17M
7.09%
--
--
Mar 19, 2025
HHLR Advisors, Ltd.
5.98M
5.19%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
1.36M
1.18%
+1.30M
+2235.39%
Sep 30, 2025
Invus Public Equities Advisors, LLC
1.17M
1.01%
+1.17M
--
Sep 30, 2025
Candriam Luxembourg S.A.
1.61M
1.4%
+2.26K
+0.14%
Nov 30, 2025
Ariose Capital Management Limited
1.70M
1.48%
+1.61M
+1667.03%
Sep 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
๋ง์ง๋ง ์
๋ฐ์ดํธ: Tue, Dec 9
์ด๋ฆ
๋น์จ
ALPS Barron's 400 ETF
0.23%
SPDR S&P Emerging Markets Small Cap ETF
0.03%
SPDR S&P China ETF
0.01%
SPDR Portfolio Emerging Markets ETF
0.01%
ActivePassive International Equity ETF
0%
Avantis Emerging Markets Small Cap Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Invesco Golden Dragon China ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
ALPS Barron's 400 ETF
๋น์จ0.23%
SPDR S&P Emerging Markets Small Cap ETF
๋น์จ0.03%
SPDR S&P China ETF
๋น์จ0.01%
SPDR Portfolio Emerging Markets ETF
๋น์จ0.01%
ActivePassive International Equity ETF
๋น์จ0%
Avantis Emerging Markets Small Cap Equity ETF
๋น์จ0%
Invesco NASDAQ Future Gen 200 ETF
๋น์จ0%
Invesco Golden Dragon China ETF
๋น์จ0%
SPDR S&P Emerging Asia Pacific ETF
๋น์จ0%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
